P wave dispersion and maximum P wave duration are independently associated with rapid renal function decline

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Su, Ho Ming ^a,b,c   Tsai, Wei Chung ^a   Lin, Tsung Hsien ^a,c   Hsu, Po Chao ^a   Lee, Wen Hsien ^a   Lin, Ming Yen ^a   Chen, Szu Chia ^a,b   Lee, Chee Siong ^a,c   Voon, Wen Chol ^a,c   Lai, Wen Ter ^a,c   Sheu, Sheng Hsiung ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROCARDIOGRAM; FEMALE; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART RATE; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; P WAVE; P WAVE DISPERSION; P WAVE MAXIMUM DURATION; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT;

AGED; ATRIAL FIBRILLATION; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HEART RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK;

EID: 84865419579     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042815     Document Type: Article

References (47)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305.
2. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, et al. (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17: 2034-2047.
3. Khan NA, Ma I, Thompson CR, Humphries K, Salem DN, et al. (2006) Kidney function and mortality among patients with left ventricular systolic dysfunction. J Am Soc Nephrol 17: 244-253.
4. Shlipak MG, Katz R, Kestenbaum B, Siscovick D, Fried L, et al. (2009) Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 20: 2625-2630.
5. Chen SC, Lin TH, Hsu PC, Chang JM, Lee CS, et al. (2011) Impaired left ventricular systolic function and increased brachial-ankle pulse-wave velocity are independently associated with rapid renal function progression. Hypertens Res 34: 1052-1058.
6. Chen SC, Su HM, Hung CC, Chang JM, Liu WC, et al. (2011) Echocardiographic Parameters are Independently Associated with Rate of Renal Function Decline and Progression to Dialysis in Patients with Chronic Kidney Disease. Clin J Am Soc Nephrol 6: 2750-2758.
7. Furukawa M, Io H, Tanimoto M, Hagiwara S, Horikoshi S, et al. (2011) Predictive factors associated with the period of time before initiation of hemodialysis in CKD stages 4 and 5. Nephron Clin Pract 117: c341-347.
8. Faramawi MF, Caffrey JL, Amanzadeh J, Sharpa LD, Qualls-Hampton R, (2011) Cystatin c estimated renal dysfunction predicts t wave axis deviation in us adults: Results from nhanes iii. Eur J Epidemiol 26: 101-107.
9. Patane S, (2011) Torsade de pointes, qt interval prolongation and renal disease. Int J Cardiol 149: 241-242.
10. Alpert MA, Munuswamy K, (1989) Electrocardiographic diagnosis of left atrial enlargement. Arch Intern Med 149: 1161-1165.
11. Hazen MS, Marwick TH, Underwood DA, (1991) Diagnostic accuracy of the resting electrocardiogram in detection and estimation of left atrial enlargement: an echocardiographic correlation in 551 patients. Am Heart J 122: 823-828.
12. Jin L, Weisse AB, Hernandez F, Jordan T, (1988) Significance of Electrocardiographic Isolated Abnormal Terminal P-Wave Force (Left Atrial Abnormality) An Echocardiographic and Clinical Correlation. Arch Intern Med 148: 1545-1549.
13. Waggoner A, Adyanthaya A, Quinones M, Alexander J (1976) Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria. Circulation 54: 553-557, 1976.
14. Truong QA, Charipar EM, Ptaszek LM, Taylor C, Fontes JD, et al. (2011) Usefulness of electrocardiographic parameters as compared with computed tomography measures of left atrial volume enlargement: from the ROMICAT trial. Journal of Electrocardiology 44: 257-264.
15. Birkbeck JP, Wilson DB, Hall MA, Meyers DG, (2006) P-wave morphology correlation with left atrial volumes assessed by 2-dimensional echocardiography. Journal of Electrocardiology 39: 225-229.
16. Zeng C, Wei T, Zhao R, Wang C, Chen L, et al. (2003) Electrocardiographic diagnosis of left atrial enlargement in patients with mitral stenosis: the value of the P-wave area. Acta Cardiol 58: 139-141.
17. Kim DH, Kim GC, Kim SH, Yu HK, Choi WG, et al. (2007) The relationship between the left atrial volume and the maximum P-wave and P-wave dispersion in patients with congestive heart failure. Yonsei Med J 48: 810-817.
18. Yilmaz R, Demirbag R, Durmus I, Kasap H, Baykan M, et al. (2004) Association of Stage of Left Ventricular Diastolic Dysfunction with P Wave Dispersion and Occurrence of Atrial Fibrillation after First Acute Anterior Myocardial Infarction. Annals of Noninvasive Electrocardiology 9: 330-338.
19. Koz C, Uzun M, Yokusoglu M, Ulas UH, Baysan O, et al. (2008) Echocardiographic, electrocardiographic, and clinical correlates of recurrent transient ischemic attacks: a follow-up study. South Med J 101: 246-251.
20. Magnani JW, Johnson VM, Sullivan LM, Gorodeski EZ, Schnabel RB, et al. (2011) P wave duration and risk of longitudinal atrial fibrillation in persons & = 60 years old (from the Framingham Heart Study). Am J Cardiol 107: 917-921 e911.
21. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, et al. (1998) Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135: 733-738.
22. Bazett HC, (1920) The time relations of the blood-pressure changes after excision of the adrenal glands, with some observations on blood volume changes. J Physiol 53: 320-339.
23. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57: 450-458.
24. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25: 1105-1187.
25. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463.
26. Vickery S, Stevens PE, Dalton RN, van Lente F, Lamb EJ, (2006) Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays? Nephrol Dial Transplant 21: 2439-2445.
27. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
28. Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG, (2010) Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension55: 1110-1115.
29. Su HM, Lin TH, Hus PC, Chu CY, Lee WH, et al. (2012) Brachial-ankle pulse wave velocity and systolic time intervals in risk stratification for progression of renal function decline. Am J Hypertens (in press).
30. Chen SC, Chang JM, Tsai YI, Su HM, Chen HC (2012) Brachial-ankle pulse wave velocity and the ratio of brachial pre-ejection period to ejection time with renal outcomes in chronic kidney disease. Hypertens Res (in press).
31. Ronco C, (2010) Cardiorenal syndromes: Definition and classification. Contrib Nephrol 164: 33-38.
32. Chen SC, Chang JM, Tsai JC, Hsu PC, Lin TH, et al. (2010) A new systolic parameter defined as the ratio of brachial pre-ejection period to brachial ejection time predicts overall and cardiovascular mortality in hemodialysis patients. Hypertens Res 33: 492-498.
33. Chen SC, Chang JM, Tsai JC, Lin TH, Hsu PC, et al. (2010) A systolic parameter defined as the ratio of brachial pre-ejection period to brachial ejection time predicts cardiovascular events in patients with chronic kidney disease. Circ J 74: 2206-2210.
34. Bock JS, Gottlieb SS, (2010) Cardiorenal syndrome: New perspectives. Circulation 121: 2592-2600.
35. Paoletti E, Bellino D, Gallina AM, Amidone M, Cassottana P, et al. (2011) Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease? Nephrol Dial Transplant 26: 670-677.
36. Gunduz H, Binak E, Arinc H, Akdemir R, Ozhan H, et al. (2005) The relationship between P wave dispersion and diastolic dysfunction. Tex Heart Inst J 32: 163-167.
37. Buxton AE, Josephson ME, (1981) The role of p wave duration as a predictor of postoperative atrial arrhythmias. Chest 80: 68-73.
38. Soliman EZ, Prineas RJ, Case LD, Zhang Z-m, Goff DC Jr, (2009) Ethnic Distribution of ECG Predictors of Atrial Fibrillation and Its Impact on Understanding the Ethnic Distribution of Ischemic Stroke in the Atherosclerosis Risk in Communities (ARIC) Study. Stroke 40: 1204-1211.
39. Dagli N, Karaca I, Yavuzkir M, Balin M, Arslan N, (2008) Are maximum P wave duration and P wave dispersion a marker of target organ damage in the hypertensive population? Clin Res Cardiol 97: 98-104.
40. Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, et al. (2002) Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. Am Heart J 143: 1107-1111.
41. Feig DI, Kang DH, Johnson RJ, (2008) Uric acid and cardiovascular risk. N Engl J Med 359: 1811-1821.
42. Johnson RJ, Feig DI, Herrera-Acosta J, Kang DH, (2005) Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 45: 18-20.
43. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, et al. (2009) Association between serum uric acid and development of type 2 diabetes. Diabetes Care 32: 1737-1742.
44. Nakagawa T, Mazzali M, Kang DH, Sanchez-Lozada LG, Herrera-Acosta J, et al. (2006) Uric acid-a uremic toxin? Blood Purif 24: 67-70.
45. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, et al. (2009) Uric acid and long-term outcomes in ckd. Am J Kidney Dis 53: 796-803.
46. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM, (2005) Performance of the modification of diet in renal disease and cockcroft-gault equations in the estimation of gfr in health and in chronic kidney disease. J Am Soc Nephrol 16: 459-466.
47. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, et al. (2004) Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med 141: 929-937.